Successful treatment with cyclosporin A of pure red cell aplasia associated with rheumatoid arthritis

Journal of Rheumatology

Volumn 23, Issue 10, 1996, Pages 1803-1805

  Fujii, Takao ^a,c   Yajima, Tomoharu ^a   Kameda, Hideto ^a   Mimori, Tsuneyo ^a,b   Akizuki, Masashi ^a,b   Ikeda, Yasuo ^a,b  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Department of Internal Medicine ^*  (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cyclosporin A; pure red cell aplasia; rheumatoid arthritis

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; PRIORITY JOURNAL; PURE RED CELL ANEMIA; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

ARTHRITIS, RHEUMATOID; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBINS; HUMANS; MIDDLE AGED; RED-CELL APLASIA, PURE; RETICULOCYTE COUNT;

EID: 0029830272     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Ammus SS, Yunis AA: Acquired pure red cell aplasia. Am J Hematol 1987;24:311-26.
2. Raghavachar A: Pure red cell aplasia: Review of treatment and proposal for a treatment strategy. Blut 1990;61:47-51.
3. van Rijthoven AWAM, Dijkmans BAC, Goei Thè HS, et al.: Cyclosporin treatment of rheumatoid arthritis: A placebo controlled, double blind, multicentre study. Ann Rheum Dis 1986;45:726-31.
4. Yocum DE, Klippel JH, Wilder RL, et al.: Cyclosporin A in severe, treatment refractory rheumatoid arthritis: A randomized study. Ann Intern Med 1988;109:863-9.
5. Tugwell P, Bombardier C, Gent M, et al.: Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis. Lancet 1990;335:1051-5.
6. Tötterman TH, Högland M, Bengtsson M, Simonsson B, Almqvist D, Killandar A: Treatment of pure red-cell aplasia and aplastic anemia with Ciclosporin: Long-term clinical effects. Eur J Haematol 1989;42:126-33.
7. Leonard EM, Rafesky E, Griffith P, Kimball J, Nienhuis AW, Young NS: Cyclosporine therapy of aplastic anaemia, congenital and acquired red cell aplasia. Br J Haematol 1989;72:278-84.
8. Means RT Jr, Dessypris EN, Krantz SB: Treatment of refractory pure red cell aplasia with cyclosporine A: Disappearance of IgG inhibitor associated with clinical response. Br J Haematol 1991;78:114-9.
9. Chikkappa G, Pasquale D, Zarrabi MH, Weiler RJ, Divakara M, Tsan MF: Cyclosporin and prednisolone therapy for pure red cell aplasia in patients with chronic lymphocytic leukemia. Am J Haematol 1992;41:5-12.
10. Feutren G, Mihatsch MJ: Risk factor for cyclosporine-induced nephropathy in patients with autoimmune diseases. N Engl J Med 1992;326:1654-60.
11. Dessypris EN, Baer MR, Sergent JS, Krantz SB: Rheumatoid arthritis and pure red cell aplasia. Ann Intern Med 1984;100:202-6.
12. Konwalinka G, Huber C, Tomascheck B, et al.: A case of acquired pure red cell anemia studied by cloning of erythroid progenitor cells in vitro. Acta Haematol 1983;10:316-24.
13. Kimura N, Yamasaki K, Niho Y, Kisu T, Oka Y, Otuka T: Pure red cell aplasia associated with juvenile rheumatoid arthritis: Effects of T-lymphocytes on hemopoietic progenitor cells. Acta Haematol Jpn 1982;45:129-32.